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Methods:
A handheld Bruel and Kjaer 4810 minishaker provided BCV stimulation was used, using surface EMG electrodes beneath both eyes to record oVEMP n10. The stimulus ACS and BCV at either Fz or at the vertex of the skull (Cz) were tone bursts ranging from 125 Hz to 8000 Hz. Twentyseven healthy subjects were tested in the same paradigm.
Results: In response to ACS and Fz BCV from 125 Hz until 8000 Hz in SSCD patients the oVEMP n10 amplitude beneath the con-traSSCD eye was substantially and significantly larger than the oVEMP n10 beneath the ipsiSSCD eye. In normal patients, ACS oVEMPs n10 is present and reproducible until 1000 Hz, while in SSCD ACS oVEMPs n10 is present up to far higher frequencies (8000 Hz). To Fz BCV oVEMPs n10 is present until 8000 Hz in 23 patients but only to 1000 Hz in normal patients.
Conclusion:
Testing OVEMP frequency tuning with ACS and BCV allows very simple, very fast identification of a probable unilateral SSCD in a manner which is very easy even for senior patients.
Otology/Neurotology Pack or No Pack after Ear Surgery: A Randomized Controlled Trial
Faisal Javed, MD (presenter); Russell Whitwell; Ian Macleod; Daniel Hajioff, FRCS; Philip Robinson, FRCS; David Rea; Desmond Nunez, MD Objective: 1) To see if there is a difference in patient and clinician reported outcomes between patients randomized to postoperative ear packing, compared to those who did not have the ear packed after middle ear surgery. 2) To see if there is a also a difference in hearing outcome between both groups.
Method: Randomized controlled trial of adult patients to have either Bismuth Iodoform Paraffin Paste pack or no ear pack postoperatively after primary canal wall up middle ear surgery. Setting: tertiary teaching hospital, UK (2011). Outcome measures: clinicians/patients recorded visual analogue scale scores at 3 weeks and 3 months postoperatively. Audiometry was recorded at 3 months.
Results: Thirty-two patients of similar sex and age were randomized to the 2 treatment arms. There was no statistically significant inter-group difference in 3-week composite clinician and patients mean visual analogue scores (146 mm versus 184 mm [P = .3]). The graft take rates and the appearance of the ear canals at 3 months were similar in both groups (P = 1.0 for both outcomes). There was also no significant inter-group difference in the change in mean air conduction thresholds in response to surgery (11.3 dB and 3.5 dB) in the ear pack and no pack groups, respectively (P = .08).
Conclusion:
No differences in total patient symptoms and clinician findings or hearing were demonstrated between patients with a postoperative pack compared to those without a postoperative pack following middle ear surgery. This pilot study provides justification for a larger clinical trial to investigate the need for postoperative ear canal packing.
Otology/Neurotology Prevention of Biofilm Formation by Polyquaternary Polymer
Carolyn Ojano-Dirain (presenter); Patrick J. Antonelli, MD; Rodrigo C. Silva, MD; Usman Bashir Objective: Biofilm formation has been linked to otologic implant infection and extrusion. The purpose of this study was to determine if a microbicidal polyquaternary polymer (PP) could prevent biofilm development by common otopathogens, Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA).
Method: Polyurethane tubes (20 per treatment) with and without a PP were briefly exposed to plasma or saline, then to SA or PA. Tubes were incubated in growth media. After 4 days, antibiotics were added to kill planktonic bacteria. Biofilm formation was assessed by bacterial counts and scanning electron microscopy.
Results: SA biofilm was reduced by 8 logs on tubes with the PP compared to the control tubes (P < .0001). PA biofilm formation was also less on tubes with the PP (P < .0001), but the reduction was only 1 log. Plasma promoted SA and PA biofilm on the control tubes (P < .0001) but not on the tubes with the PP (P = .07 and .40 for SA and PA, respectively).
Conclusion: Incorporation of a microbicidal PP into polyurethane dramatically inhibits SA biofilm formation. Further research is warranted to evaluate the efficacy and safety of this technology in otologic implants.
